Structure

Physi-Chem Properties

Molecular Weight:  354.15
Volume:  363.042
LogP:  5.036
LogD:  3.694
LogS:  -4.046
# Rotatable Bonds:  3
TPSA:  68.15
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.808
Synthetic Accessibility Score:  3.641
Fsp3:  0.333
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.828
MDCK Permeability:  1.1481900401122402e-05
Pgp-inhibitor:  0.018
Pgp-substrate:  0.08
Human Intestinal Absorption (HIA):  0.012
20% Bioavailability (F20%):  0.555
30% Bioavailability (F30%):  0.11

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.021
Plasma Protein Binding (PPB):  96.48275756835938%
Volume Distribution (VD):  0.973
Pgp-substrate:  5.774430751800537%

ADMET: Metabolism

CYP1A2-inhibitor:  0.566
CYP1A2-substrate:  0.937
CYP2C19-inhibitor:  0.875
CYP2C19-substrate:  0.441
CYP2C9-inhibitor:  0.887
CYP2C9-substrate:  0.884
CYP2D6-inhibitor:  0.787
CYP2D6-substrate:  0.827
CYP3A4-inhibitor:  0.613
CYP3A4-substrate:  0.555

ADMET: Excretion

Clearance (CL):  13.15
Half-life (T1/2):  0.347

ADMET: Toxicity

hERG Blockers:  0.054
Human Hepatotoxicity (H-HT):  0.925
Drug-inuced Liver Injury (DILI):  0.867
AMES Toxicity:  0.475
Rat Oral Acute Toxicity:  0.291
Maximum Recommended Daily Dose:  0.939
Skin Sensitization:  0.886
Carcinogencity:  0.117
Eye Corrosion:  0.003
Eye Irritation:  0.783
Respiratory Toxicity:  0.636

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC102044

Natural Product ID:  NPC102044
Common Name*:   Eryvarin K
IUPAC Name:   (6aR,11aR)-8-methoxy-2-(3-methylbut-2-enyl)-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromene-3,9-diol
Synonyms:   Eryvarin K
Standard InCHIKey:  CVUYVQZALVRDIK-BTYIYWSLSA-N
Standard InCHI:  InChI=1S/C21H22O5/c1-11(2)4-5-12-6-14-18(8-16(12)22)25-10-15-13-7-20(24-3)17(23)9-19(13)26-21(14)15/h4,6-9,15,21-23H,5,10H2,1-3H3/t15-,21-/m0/s1
SMILES:  CC(=CCc1cc2c(cc1O)OC[C@H]1c3cc(c(cc3O[C@@H]21)O)OC)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1079408
PubChem CID:   11187348
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0002617] Furanoisoflavonoids
          • [CHEMONTID:0001608] Pterocarpans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota stem bark n.a. n.a. PMID[17489632]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. stem n.a. PMID[18484536]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota stem bark Mukono, Uganda 2005-JUN PMID[19008110]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[19299148]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[19836230]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[20337486]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[21116437]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO8526 Erythrina abyssinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens IC50 > 30000.0 nM PMID[456054]
NPT83 Cell Line MCF7 Homo sapiens IC50 > 30000.0 nM PMID[456054]
NPT82 Cell Line MDA-MB-231 Homo sapiens IC50 > 30000.0 nM PMID[456054]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC102044 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC47633
1.0 High Similarity NPC85264
0.9926 High Similarity NPC93323
0.9926 High Similarity NPC280092
0.9926 High Similarity NPC63879
0.9926 High Similarity NPC45257
0.9926 High Similarity NPC12641
0.9852 High Similarity NPC247291
0.9779 High Similarity NPC107161
0.9778 High Similarity NPC259519
0.9712 High Similarity NPC101376
0.9712 High Similarity NPC21776
0.9712 High Similarity NPC16269
0.9632 High Similarity NPC254759
0.9632 High Similarity NPC27495
0.9632 High Similarity NPC160283
0.9632 High Similarity NPC309124
0.9632 High Similarity NPC184797
0.9562 High Similarity NPC87725
0.9562 High Similarity NPC311530
0.9562 High Similarity NPC263261
0.9562 High Similarity NPC471389
0.9559 High Similarity NPC319647
0.9559 High Similarity NPC236306
0.9559 High Similarity NPC70682
0.9559 High Similarity NPC245207
0.9559 High Similarity NPC473739
0.9559 High Similarity NPC292882
0.9559 High Similarity NPC232164
0.9559 High Similarity NPC25966
0.9559 High Similarity NPC127218
0.9559 High Similarity NPC260741
0.9496 High Similarity NPC50250
0.9485 High Similarity NPC102904
0.9485 High Similarity NPC107551
0.9485 High Similarity NPC326797
0.9485 High Similarity NPC474282
0.9485 High Similarity NPC176051
0.9485 High Similarity NPC276490
0.9485 High Similarity NPC103976
0.9429 High Similarity NPC307466
0.9424 High Similarity NPC477616
0.942 High Similarity NPC35216
0.9416 High Similarity NPC471388
0.9412 High Similarity NPC248727
0.9412 High Similarity NPC173660
0.9412 High Similarity NPC265433
0.9412 High Similarity NPC470802
0.9412 High Similarity NPC270456
0.9412 High Similarity NPC162659
0.9375 High Similarity NPC160196
0.9366 High Similarity NPC71726
0.9362 High Similarity NPC260397
0.9357 High Similarity NPC473108
0.9353 High Similarity NPC204347
0.9353 High Similarity NPC2613
0.9353 High Similarity NPC59841
0.9353 High Similarity NPC475891
0.9343 High Similarity NPC477938
0.9338 High Similarity NPC234333
0.9338 High Similarity NPC121812
0.9338 High Similarity NPC134968
0.9338 High Similarity NPC112246
0.9338 High Similarity NPC112939
0.9338 High Similarity NPC47398
0.9338 High Similarity NPC260898
0.9338 High Similarity NPC94750
0.9338 High Similarity NPC473413
0.9338 High Similarity NPC474206
0.9338 High Similarity NPC470356
0.9338 High Similarity NPC195022
0.9291 High Similarity NPC469557
0.9275 High Similarity NPC32630
0.927 High Similarity NPC230734
0.927 High Similarity NPC227503
0.927 High Similarity NPC29799
0.927 High Similarity NPC472336
0.927 High Similarity NPC10737
0.927 High Similarity NPC177160
0.927 High Similarity NPC263367
0.927 High Similarity NPC474639
0.927 High Similarity NPC477939
0.927 High Similarity NPC156502
0.927 High Similarity NPC54743
0.927 High Similarity NPC16435
0.927 High Similarity NPC209985
0.927 High Similarity NPC306441
0.927 High Similarity NPC472334
0.9265 High Similarity NPC193026
0.9265 High Similarity NPC187616
0.9265 High Similarity NPC49603
0.9265 High Similarity NPC317380
0.9265 High Similarity NPC474478
0.9259 High Similarity NPC204215
0.9259 High Similarity NPC127624
0.9259 High Similarity NPC175067
0.9247 High Similarity NPC188578
0.9247 High Similarity NPC80918
0.9247 High Similarity NPC159922
0.9236 High Similarity NPC472709
0.9236 High Similarity NPC472710
0.9231 High Similarity NPC301961
0.9231 High Similarity NPC166584
0.9225 High Similarity NPC226540
0.9203 High Similarity NPC211549
0.9197 High Similarity NPC151224
0.9197 High Similarity NPC61946
0.9197 High Similarity NPC472337
0.9191 High Similarity NPC11060
0.9191 High Similarity NPC158331
0.9155 High Similarity NPC181615
0.9149 High Similarity NPC81638
0.9143 High Similarity NPC265075
0.913 High Similarity NPC78047
0.913 High Similarity NPC234952
0.913 High Similarity NPC302701
0.913 High Similarity NPC269091
0.9124 High Similarity NPC124085
0.9124 High Similarity NPC287745
0.9124 High Similarity NPC16485
0.9124 High Similarity NPC478085
0.9124 High Similarity NPC117048
0.9124 High Similarity NPC106215
0.9124 High Similarity NPC244983
0.9124 High Similarity NPC326095
0.9118 High Similarity NPC6451
0.9118 High Similarity NPC202762
0.9118 High Similarity NPC86655
0.9111 High Similarity NPC214860
0.9111 High Similarity NPC27187
0.9111 High Similarity NPC470225
0.9097 High Similarity NPC20757
0.9097 High Similarity NPC473408
0.9097 High Similarity NPC227516
0.9091 High Similarity NPC112251
0.9091 High Similarity NPC324492
0.9091 High Similarity NPC233980
0.9091 High Similarity NPC317053
0.9078 High Similarity NPC41782
0.9065 High Similarity NPC474687
0.9058 High Similarity NPC256262
0.9058 High Similarity NPC34103
0.9058 High Similarity NPC164787
0.9058 High Similarity NPC165155
0.9058 High Similarity NPC99572
0.9058 High Similarity NPC126409
0.9058 High Similarity NPC141765
0.9058 High Similarity NPC24490
0.9051 High Similarity NPC475840
0.9051 High Similarity NPC105554
0.9051 High Similarity NPC26394
0.9051 High Similarity NPC85435
0.9051 High Similarity NPC263064
0.9051 High Similarity NPC168059
0.9051 High Similarity NPC229442
0.9044 High Similarity NPC280653
0.9044 High Similarity NPC476166
0.9044 High Similarity NPC164574
0.9044 High Similarity NPC300875
0.9044 High Similarity NPC12275
0.9044 High Similarity NPC220825
0.9044 High Similarity NPC12875
0.9044 High Similarity NPC17343
0.9044 High Similarity NPC181497
0.9044 High Similarity NPC42760
0.9044 High Similarity NPC268342
0.9044 High Similarity NPC45715
0.9044 High Similarity NPC118114
0.9044 High Similarity NPC268266
0.9044 High Similarity NPC129106
0.9044 High Similarity NPC150011
0.9044 High Similarity NPC129784
0.9044 High Similarity NPC196765
0.9044 High Similarity NPC268917
0.9044 High Similarity NPC236014
0.9044 High Similarity NPC474356
0.9044 High Similarity NPC207892
0.9044 High Similarity NPC206224
0.9044 High Similarity NPC228369
0.9044 High Similarity NPC271945
0.9044 High Similarity NPC232275
0.9041 High Similarity NPC2745
0.9037 High Similarity NPC45824
0.9034 High Similarity NPC240521
0.9034 High Similarity NPC211561
0.9028 High Similarity NPC474397
0.9028 High Similarity NPC327412
0.9028 High Similarity NPC328567
0.9028 High Similarity NPC320970
0.9028 High Similarity NPC320671
0.9021 High Similarity NPC221318
0.9021 High Similarity NPC472457
0.9021 High Similarity NPC90645
0.9021 High Similarity NPC474749
0.9021 High Similarity NPC178014
0.9021 High Similarity NPC11422
0.9021 High Similarity NPC42716
0.9021 High Similarity NPC180953
0.9014 High Similarity NPC258083
0.9014 High Similarity NPC474104

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC102044 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8978 High Similarity NPD1612 Clinical (unspecified phase)
0.8978 High Similarity NPD1613 Approved
0.8889 High Similarity NPD1530 Clinical (unspecified phase)
0.8824 High Similarity NPD1529 Clinical (unspecified phase)
0.8759 High Similarity NPD3027 Phase 3
0.8561 High Similarity NPD4907 Clinical (unspecified phase)
0.8478 Intermediate Similarity NPD2861 Phase 2
0.8417 Intermediate Similarity NPD4908 Phase 1
0.8309 Intermediate Similarity NPD1610 Phase 2
0.8247 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD1934 Approved
0.8153 Intermediate Similarity NPD6234 Discontinued
0.8101 Intermediate Similarity NPD5494 Approved
0.8099 Intermediate Similarity NPD4625 Phase 3
0.8058 Intermediate Similarity NPD4749 Approved
0.8042 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.8039 Intermediate Similarity NPD1653 Approved
0.8013 Intermediate Similarity NPD2801 Approved
0.7987 Intermediate Similarity NPD6674 Discontinued
0.7949 Intermediate Similarity NPD37 Approved
0.7914 Intermediate Similarity NPD7228 Approved
0.7911 Intermediate Similarity NPD4967 Phase 2
0.7911 Intermediate Similarity NPD4966 Approved
0.7911 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7911 Intermediate Similarity NPD4965 Approved
0.7883 Intermediate Similarity NPD1548 Phase 1
0.7867 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7866 Intermediate Similarity NPD5844 Phase 1
0.7808 Intermediate Similarity NPD4060 Phase 1
0.7808 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7808 Intermediate Similarity NPD3620 Phase 2
0.7799 Intermediate Similarity NPD3882 Suspended
0.7791 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD6166 Phase 2
0.7791 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD7199 Phase 2
0.7708 Intermediate Similarity NPD3018 Phase 2
0.7697 Intermediate Similarity NPD3818 Discontinued
0.7647 Intermediate Similarity NPD5283 Phase 1
0.7622 Intermediate Similarity NPD6696 Suspended
0.7622 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7605 Intermediate Similarity NPD7074 Phase 3
0.76 Intermediate Similarity NPD5588 Approved
0.7552 Intermediate Similarity NPD2983 Phase 2
0.7552 Intermediate Similarity NPD2982 Phase 2
0.7548 Intermediate Similarity NPD1511 Approved
0.7545 Intermediate Similarity NPD7054 Approved
0.7536 Intermediate Similarity NPD6671 Approved
0.7535 Intermediate Similarity NPD3705 Approved
0.7533 Intermediate Similarity NPD4536 Approved
0.7533 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7533 Intermediate Similarity NPD4538 Approved
0.7517 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7517 Intermediate Similarity NPD5124 Phase 1
0.7517 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD8651 Approved
0.75 Intermediate Similarity NPD228 Approved
0.75 Intermediate Similarity NPD7472 Approved
0.7484 Intermediate Similarity NPD5058 Phase 3
0.7484 Intermediate Similarity NPD4380 Phase 2
0.7483 Intermediate Similarity NPD2981 Phase 2
0.7471 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD7549 Discontinued
0.7468 Intermediate Similarity NPD6331 Phase 2
0.7453 Intermediate Similarity NPD1465 Phase 2
0.7452 Intermediate Similarity NPD1512 Approved
0.7434 Intermediate Similarity NPD6100 Approved
0.7434 Intermediate Similarity NPD6099 Approved
0.7431 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD7075 Discontinued
0.7421 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD1091 Approved
0.7412 Intermediate Similarity NPD6559 Discontinued
0.7412 Intermediate Similarity NPD7240 Approved
0.7407 Intermediate Similarity NPD3817 Phase 2
0.7407 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7399 Intermediate Similarity NPD4663 Approved
0.7389 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD5960 Phase 3
0.7365 Intermediate Similarity NPD27 Approved
0.7365 Intermediate Similarity NPD2489 Approved
0.7356 Intermediate Similarity NPD7906 Approved
0.7355 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD3021 Approved
0.7353 Intermediate Similarity NPD3022 Approved
0.7353 Intermediate Similarity NPD6797 Phase 2
0.7353 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD6232 Discontinued
0.7346 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7341 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD1558 Phase 1
0.7329 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD7310 Approved
0.7326 Intermediate Similarity NPD7312 Approved
0.7326 Intermediate Similarity NPD7311 Approved
0.7326 Intermediate Similarity NPD4577 Approved
0.7326 Intermediate Similarity NPD7313 Approved
0.7326 Intermediate Similarity NPD4578 Approved
0.7325 Intermediate Similarity NPD7213 Phase 3
0.7325 Intermediate Similarity NPD7212 Phase 2
0.7321 Intermediate Similarity NPD7473 Discontinued
0.7315 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD7251 Discontinued
0.731 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD2970 Approved
0.7305 Intermediate Similarity NPD2969 Approved
0.729 Intermediate Similarity NPD5177 Phase 3
0.729 Intermediate Similarity NPD1652 Phase 2
0.7289 Intermediate Similarity NPD6959 Discontinued
0.7285 Intermediate Similarity NPD6355 Discontinued
0.7285 Intermediate Similarity NPD5735 Approved
0.7283 Intermediate Similarity NPD7309 Approved
0.7278 Intermediate Similarity NPD7447 Phase 1
0.7273 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD5763 Approved
0.7273 Intermediate Similarity NPD7266 Discontinued
0.7273 Intermediate Similarity NPD5762 Approved
0.7267 Intermediate Similarity NPD4675 Approved
0.7267 Intermediate Similarity NPD4678 Approved
0.7267 Intermediate Similarity NPD7808 Phase 3
0.7255 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD3051 Approved
0.7246 Intermediate Similarity NPD7229 Phase 3
0.7244 Intermediate Similarity NPD7466 Approved
0.7244 Intermediate Similarity NPD3892 Phase 2
0.7239 Intermediate Similarity NPD7819 Suspended
0.7239 Intermediate Similarity NPD5929 Approved
0.7234 Intermediate Similarity NPD7340 Approved
0.7226 Intermediate Similarity NPD1549 Phase 2
0.7226 Intermediate Similarity NPD2424 Discontinued
0.7212 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD4005 Discontinued
0.7186 Intermediate Similarity NPD1247 Approved
0.7184 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD8053 Approved
0.7184 Intermediate Similarity NPD8054 Approved
0.7172 Intermediate Similarity NPD422 Phase 1
0.717 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7163 Intermediate Similarity NPD7157 Approved
0.7161 Intermediate Similarity NPD3540 Phase 1
0.7153 Intermediate Similarity NPD2684 Approved
0.7152 Intermediate Similarity NPD6233 Phase 2
0.7143 Intermediate Similarity NPD1398 Phase 1
0.7135 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD4110 Phase 3
0.7132 Intermediate Similarity NPD968 Approved
0.7125 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD4750 Phase 3
0.7097 Intermediate Similarity NPD2935 Discontinued
0.7097 Intermediate Similarity NPD3539 Phase 1
0.7091 Intermediate Similarity NPD2563 Approved
0.7091 Intermediate Similarity NPD2560 Approved
0.7091 Intermediate Similarity NPD5402 Approved
0.7089 Intermediate Similarity NPD2677 Approved
0.7088 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD6798 Discontinued
0.7083 Intermediate Similarity NPD1357 Approved
0.708 Intermediate Similarity NPD290 Approved
0.7075 Intermediate Similarity NPD5327 Phase 3
0.7073 Intermediate Similarity NPD3382 Approved
0.7073 Intermediate Similarity NPD6801 Discontinued
0.7073 Intermediate Similarity NPD3383 Approved
0.7073 Intermediate Similarity NPD3384 Approved
0.7071 Intermediate Similarity NPD7843 Approved
0.707 Intermediate Similarity NPD4237 Approved
0.707 Intermediate Similarity NPD4236 Phase 3
0.7063 Intermediate Similarity NPD2532 Approved
0.7063 Intermediate Similarity NPD2533 Approved
0.7063 Intermediate Similarity NPD2534 Approved
0.7063 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD3657 Discovery
0.7051 Intermediate Similarity NPD6004 Phase 3
0.7051 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD1375 Discontinued
0.7051 Intermediate Similarity NPD6002 Phase 3
0.7051 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD6005 Phase 3
0.7048 Intermediate Similarity NPD7768 Phase 2
0.7047 Intermediate Similarity NPD6584 Phase 3
0.7044 Intermediate Similarity NPD7124 Phase 2
0.7041 Intermediate Similarity NPD3787 Discontinued
0.7041 Intermediate Similarity NPD6071 Discontinued
0.7034 Intermediate Similarity NPD5125 Phase 3
0.7034 Intermediate Similarity NPD5126 Approved
0.703 Intermediate Similarity NPD8455 Phase 2
0.7025 Intermediate Similarity NPD4535 Phase 3
0.7025 Intermediate Similarity NPD3750 Approved
0.702 Intermediate Similarity NPD7095 Approved
0.7013 Intermediate Similarity NPD4097 Suspended
0.7012 Intermediate Similarity NPD7411 Suspended

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data